Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- The ATHENA study

British Journal of Haematology

Volumn 166, Issue 4, 2014, Pages 581-591

  Estcourt, Lise J ^a,b   Stanworth, Simon J ^a,b   Harrison, Paul ^c   Powter, Gillian ^a   Mcclure, Marianne ^d   Murphy, Michael F ^a,b   Mumford, Andrew D ^e  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Haematological malignancies; Haemorrhage; Rotational thromboelastometry; Thrombocytopenia; Transfusion

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOTTING; CENTRIFUGATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEMATOLOGIC MALIGNANCY; HEMATOLOGICAL PROCEDURE; HEMOSTASIS; HUMAN; MALE; OBSERVATIONAL STUDY; PARTIAL THROMBOPLASTIN TIME; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE TRANSFUSION; THROMBOELASTOMETRY; YOUNG ADULT;

HAEMATOLOGICAL MALIGNANCIES; HAEMORRHAGE; ROTATIONAL THROMBOELASTOMETRY; THROMBOCYTOPENIA; TRANSFUSION;

ADULT; AGED; BLOOD COAGULATION; BLOOD PLATELETS; FEMALE; HEMATOLOGIC NEOPLASMS; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; PROSPECTIVE STUDIES; ROC CURVE; THROMBELASTOGRAPHY; THROMBOCYTOPENIA; YOUNG ADULT;

EID: 84904998341     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12928     Document Type: Article

References (40)

1. Álamo, J.M., León, A., Mellado, P., Bernal, C., Marín, L.M., Cepeda, C., Suárez, G., Serrano, J., Padillo, J. & Gómez, M.Á. (2013) Is "intra-operating room" thromboelastometry useful in liver transplantation? a case-control study in 303 patients. Transplantation Proceedings, 45, 3637-3639.
2. Barsam, S.J., Psaila, B., Forestier, M., Page, L.K., Sloane, P.A., Geyer, J.T., Villarica, G.O., Ruisi, M.M., Gernsheimer, T.B., Beer, J.H. & Bussel, J.B. (2011) Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia. Blood, 117, 5723-5732.
3. Bat, T., Leitman, S.F., Calvo, K.R., Chauvet, D. & Dunbar, C.E. (2013) Measurement of the absolute immature platelet number reflects marrow production and is not impacted by platelet transfusion. Transfusion, 53, 1201-1204.
4. BCSH (2003) British Committee for Standards in Haematology: guidelines for the use of platelet transfusions. British Journal of Haematology, 122, 10-23.
5. Blumberg, N., Spinelli, S.L., Francis, C.W., Taubman, M.B. & Phipps, R.P. (2009) The platelet as an immune cell-CD40 ligand and transfusion immunomodulation. Immunology Research, 45, 251-260.
6. Bolton-Maggs, P.H.B. (Ed), Poles, D., Watt, A., Thomas, D. & Cohen, H. on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group (2013) The 2012 Annual SHOT Report, p. 200. © Serious Hazards of Transfusion (SHOT) 2012. ISBN 978-0-9668648-5-8.
7. Briggs, C., Kunka, S., Hart, D., Oguni, S. & Machin, S.J. (2004) Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. British Journal of Haematology, 126, 93-99.
8. Briggs, C., Hart, D., Kunka, S., Oguni, S. & Machin, S.J. (2006) Immature platelet fraction measurement: a future guide to platelet transfusion requirement after haematopoietic stem cell transplantation. Transfusion Medicine, 16, 101-109.
9. Burnett, A.K., Hills, R.K., Milligan, D., Kjeldsen, L., Kell, J., Russell, N.H., Yin, J.A.L., Hunter, A., Goldstone, A.H. & Wheatley, K. (2011) Identification of patients with acute myeloblastic leukemia who benefit from the addition of Gemtuzumab Ozogamicin: results of the MRC AML15 trial. Journal of Clinical Oncology, 29, 369-377.
10. ®). British Journal of Haematology, 117, 961-964.
11. Estcourt, L.J., Birchall, J., Lowe, D., Grant-Casey, J., Rowley, M. & Murphy, M.F. (2012) Platelet transfusions in haematology patients: are we using them appropriately? Vox Sanguinis, 103, 284-293.
12. Fager, A.M., Wood, J.P., Bouchard, B.A., Feng, P. & Tracy, P.B. (2010) Properties of procoagulant platelets: defining and characterizing the subpopulation binding a functional prothrombinase. Arteriosclerosis, Thrombosis, and Vascular Biology, 30, 2400-2407.
13. Fielding, A.K., Richards, S.M., Chopra, R., Lazarus, H.M., Litzow, M.R., Buck, G., Durrant, I.J., Luger, S.M., Marks, D.I., Franklin, I.M., McMillan, A.K., Tallman, M.S., Rowe, J.M. & Goldstone, A.H. (2007) Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study. Blood, 109, 944-950.
14. Ganter, M.T. & Hofer, C.K. (2008) Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesthesia and Analgesia, 106, 1366-1375.
15. Greeno, E., McCullough, J. & Weisdorf, D. (2007) Platelet utilization and the transfusion trigger: a prospective analysis. Transfusion, 47, 201-205.
16. Guthikonda, S., Lev, E.I., Patel, R., Delao, T., Bergeron, A.L., Dong, J.F. & Kleiman, N.S. (2007) Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin. Journal of Thrombosis and Haemostasis, 5, 490-496.
17. Have, L.W., Hasle, H., Vestergaard, E.M. & Kjaersgaard, M. (2013) Absolute immature platelet count may predict imminent platelet recovery in thrombocytopenic children following chemotherapy. Pediatric Blood & Cancer, 60, 1198-1203.
18. ® closure time in the evaluation of platelet disorders and platelet function. Journal of Thrombosis and Haemostasis, 4, 312-319.
19. Heddle, N. & Webert, K. (2009) Investigation of acute transfusion reactions. In: Practical Transfusion Medicine (ed. by M. Murphy & D. Pamphilion ), pp. 63-89. Blackwell, Oxford.
20. Heddle, N., Cook, R., Tinmouth, A., Kouroukis, C., Hervig, T., Klapper, E., JM, B., Szczepiorkowski, Z., AuBuchon, J., Barty, R. & Lee, K. (2009) A randomized controlled trial comparing standard and low dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia. Blood, 113, 1564-1573.
21. Kaito, K., Otsubo, H., Usui, N., Yoshida, M., Tanno, J., Kurihara, E., Matsumoto, K., Hirata, R., Domitsu, K. & Kobayashi, M. (2005) Platelet size deviation width, platelet large cell ratio, and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopenia. British Journal of Haematology, 128, 698-702.
22. Lang, T., Johanning, K., Metzler, H., Piepenbrock, S., Solomon, C., Rahe-Meyer, N. & Tanaka, K. (2009) The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesthesia and Analgesia, 108, 751-758.
23. Latger-Cannard, V., Hoarau, M., Salignac, S., Baumgart, D., Nurden, P. & Lecompte, T. (2012) Mean platelet volume: comparison of three analysers towards standardization of platelet morphological phenotype. International Journal of Laboratory Hematology, 34, 300-310.
24. Luddington, R.J. (2005) Thrombelastography/thromboelastometry. Clinical & Laboratory Haematology, 27, 81-90.
25. Milligan, D.W., Wheatley, K., Littlewood, T., Craig, J.I.O. & Burnett, A.K. & for the NCRI Haematological Oncology Clinical Studies Group (2006) Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial. Blood, 107, 4614-4622.
26. National Blood Authority (2012) The national blood authority's patient blood management guideline: module 3 - medical. In: The National Blood Authority's Patient Blood Management Guideline (ed. by National Blood Authority), National Blood Authority, Canberra, Australia.
27. Pendry, K. & Davies, T. (2011) An audit of the use and wastage in the North West of England and North Wales - where have all the platelets gone? Blood and Transfusion Matters, 34, 17-19.
28. Popovsky, M. & Moore, S. (1985) Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion, 25, 573-577.
29. Raza, I., Davenport, R., Rourke, C., Platton, S., Manson, J., Spoors, C., Khan, S., De'Ath, H., Allard, S., Hart, D., John Pasi, K., Hunt, B.J., Stanworth, S., MacCallum, P. & Brohi, K. (2013) The incidence and magnitude of fibrinolytic activation in trauma patients. Journal of Thrombosis and Haemostasis, 11, 307-314.
30. Schiffer, C.A., Anderson, K.C., Bennett, C.L., Bernstein, S., Elting, L.S., Goldsmith, M., Goldstein, M., Hume, H., McCullough, J.J., McIntyre, R.E., Powell, B.L., Rainey, J.M., Rowley, S.D., Rebulla, P., Troner, M.B. & Wagnon, A.H. (2001) Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. Journal of Clinical Oncology, 19, 1519-1538.
31. Slichter, S.J., Kaufman, R.M., Assmann, S.F., McCullough, J., Triulzi, D.J., Strauss, R.G., Gernsheimer, T.B., Ness, P.M., Brecher, M.E., Josephson, C.D., Konkle, B.A., Woodson, R.D., Ortel, T.L., Hillyer, C.D., Skerrett, D.L., McCrae, K.R., Sloan, S.R., Uhl, L., George, J.N., Aquino, V.M., Manno, C.S., McFarland, J.G., Hess, J.R., Leissinger, C. & Granger, S. (2010) Dose of prophylactic platelet transfusions and prevention of hemorrhage. New England Journal of Medicine, 362, 600-613.
32. Solomon, C., Cadamuro, J., Ziegler, B., Schöchl, H., Varvenne, M., Sørensen, B., Hochleitner, G. & Rahe-Meyer, N. (2011) A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients. Transfusion, 51, 1695-1706.
33. Stanworth, S.J., Dyer, C., Choo, L., Bakrania, L., Copplestone, A., Llewelyn, C., Norfolk, D., Powter, G., Littlewood, T., Wood, E.M. & Murphy, M.F. (2010) Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions. Transfusion Medicine Reviews, 24, 163-171.
34. Stanworth, S.J., Estcourt, L.J., Powter, G., Kahan, B., Dyer, C., Choo, L., Bakrania, L., Llewelyn, C., Littlewood, T., Soutar, R., Norfolk, D., Copplestone, A., Smith, N., Kerr, P., Jones, G., Raj, K., Westerman, D., Szer, J., Jackson, N., Bardy, P., Plews, D., Lyons, S., Bielby, L., Wood, E.M. & Murphy, M. (2013) A no-prophylaxis platelet transfusion strategy for hematologic cancers. New England Journal of Medicine, 368, 1771-1780.
35. Taylor, C.E., Cohen, H., Mold, D., Jones, H., Davies, T., Mistry, H., Ball, J., Asher, D., Cawley, C., Chaffe, B., Chapman, C., Gray, A., Jones, J., Milkins, C., New, H., Norfolk, D., Regan, F., Still, E. & Tinegate, H. on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group (2010) The 2009 annual SHOT report. p. 153. © Serious Hazards of Transfusion (SHOT) 2009. ISBN 978-0-9558648-2-7.
36. Wandt, H., Schaefer-Eckart, K., Wendelin, K., Pilz, B., Wilhelm, M., Thalheimer, M., Mahlknecht, U., Ho, A., Schaich, M., Kramer, M., Kaufmann, M., Leimer, L., Schwerdtfeger, R., Conradi, R., Dolken, G., Klenner, A., Hanel, M., Herbst, R., Junghanss, C. & Ehninger, G. (2012) Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study. Lancet, 380, 1309-1316.
37. Weber, C.F., Gorlinger, K., Meininger, D., Herrmann, E., Bingold, T., Moritz, A., Cohn, L.H. & Zacharowski, K. (2012) Point-of-care testing: a prospective, randomized clinical trial of efficacy in Coagulopathic cardiac surgery patients. Anesthesiology, 117, 531-547.
38. Whitaker, B.I. & Hinkins, S. (2013) The 2011 National Blood Collection and Utilization Survey Report. (ed. by the US Department of Health and Human Services). US Department of Health and Human Services, Rockville, Maryland.
39. Whitaker, B.I., Schlumpf, K., Schulman, J. & Green, J. (2011) Report of the US Department of Health and Human Services. The 2009 national blood collection and utilization survey report. US Department of Health and Human Services, Office of the Assistant Secretary for Health, Washington, DC.
40. Williamson, L.M. & Devine, D.V. (2013) Challenges in the management of the blood supply. The Lancet, 381, 1866-1875.